Effect of Aronia Berry Consumption on Inflammatory Parameters
The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters. It will be conducted at a research hospital in Istanbul, involving
| Condition(s) | COPD (Chronic Obstructive Pulmonary Disease) |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters. It will be conducted at a research hospital in Istanbul, involving 50 participants aged 50-80 diagnosed with COPD. Participants will be randomly assigned to two groups: the aronia group (AG, n=25) and the placebo group (PG, n=25). The AG will receive 30 g of freeze-dried aronia powder daily, while the PG will receive 30 g of placebo powder, both for a duration of 8 weeks. Baseline demographic data will be collected through face-to-face interviews, while biochemical, respiratory, anthropometric, and body composition parameters will be assess |
| Who can participate | Inclusion Criteria: * Aged 50-80 years * Diagnosed with COPD * Not following a vegetarian or vegan diet * Willing to consume the provided aronia berry (black chokeberry) * Non-smokers * Have signed the informed consent form * Has not undergone endobronchial tube or valve surgery in the last two years. Exclusion Criteria: * Presence of associated chronic inflammatory/rheumatic diseases * Chronic infections that may create a prothrombotic state * Chronic kidney disease (CKD) * Malignancy * Hereditary thrombophilia * Essential thrombocythemia * Diagnosed endocrine disorders * Malabsorption disorders * Allergy to any food or berry fruits * Smoking * Participants who did not sign the informed consent form |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Lead sponsor | Amasya University |
| Locations | Istanbul, Zeytinburnu, Turkey (Türkiye) |
| Start date | 2024-11-15 |
| NCT ID | NCT06702696 |
| Official listing | https://clinicaltrials.gov/study/NCT06702696 |